NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

I wasn’t arguing just expanding on factors affecting timing and quantity of production/storage/distribution sites and rationale. I’ll reread the posts however I don’t think I disagreed with you, rather addressing the third party, if I’m remembering accurately.

Also, only relating to the first DCVax L approvals. Later, if and when approvals for other indications arise, these other indications could potentially involve much larger numbers of patients to be treated and production will need to scale greatly. But that’s probably a couple years away unless a broad approval is granted, and even under that circumstance you’d think some proof of efficacy would be needed.